Testing effectiveness (Phase 2)Active Not RecruitingNCT02632344
What this trial is testing
Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients
Who this might be right for
Recurrent Respiratory Papillomatosis
Massachusetts General Hospital 21